Multi Drug Resistant Hiv - Pharma

Relevant Publications

Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1.

Issue Release: 2024

Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort.

Issue Release: 2024

Increasing circulation of multi-drug resistant tuberculosis strains in Buryatia, high-burden and ethnically diverse region in the Russian Far East.

Issue Release: 2024

Burden of multidrug-resistant bacteria among HIV-positive individuals in Ethiopia: A systematic review and meta-analysis.

Issue Release: 2024

In Silico Drug Repurposing Endorse Amprenavir, Darunavir and Saquinavir to Target Enzymes of Multidrug Resistant Uropathogenic .

Issue Release: 2024

The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.

Issue Release: 2024

Impact of bedaquiline regimen on the treatment success rates of multidrug-resistant tuberculosis patients in Egypt.

Issue Release: 2024

Multi-Locus Sequence Typing-Based Genetic Analysis, Antifungal Resistance, and Clinical Prognosis of Cryptococcus neoformans Infections in HIV-Infected Patients in Northern China.

Issue Release: 2024

Association of Sickle Cell Disease, Malaria and HIV in Multi Drug Resistant Invasive Non-typhoidal Isolated from Outpatient and Hospitalised Children Below 16 Years in Informal Settlements in Nairobi County, Kenya.

Issue Release: 2024

Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda.

Issue Release: 2024

Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.

Issue Release: 2024

Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir.

Issue Release: 2024

Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery.

Issue Release: 2024

A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.

Issue Release: 2024

Uro-pathogens: Multidrug resistance and associated factors of community-acquired UTI among HIV patients attending antiretroviral therapy in Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Issue Release: 2024

A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study.

Issue Release: 2024

Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis.

Issue Release: 2024

Structural and Mechanistic Bases for Resistance of the M66I Capsid Variant to Lenacapavir.

Issue Release: 2024

Antimicrobial susceptibility patterns of urinary tract infections causing bacterial isolates and associated risk factors among HIV patients in Tigray, Northern Ethiopia.

Issue Release: 2024

A complex case study: coexistence of multi-drug-resistant pulmonary tuberculosis, HBV-related liver failure, and disseminated cryptococcal infection in an AIDS patient.

Issue Release: 2024

What is Medication Adherence?

What is the Future of Patient Education in Pharma?

What are Adverse Drug Events?

What Are the Challenges in Managing Chronic Conditions?

What are the Challenges Faced by Generic Manufacturers?

What Should Be Included in Patient Education Materials?

How Long Does the Approval Process Take?

What is a New Drug Application (NDA)?

What Role Does Technology Play?

What Education and Training Do Pharmacists Need?

Multi Drug Resistant Hiv - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics